| Follow-up of adults with noncritical COVID-19 two months after symptom onset C Carvalho-Schneider, E Laurent, A Lemaignen, E Beaufils, ... Clinical microbiology and infection 27 (2), 258-263, 2021 | 866 | 2021 |
| Clinical features and prognostic factors of listeriosis: the MONALISA national prospective cohort study C Charlier, É Perrodeau, A Leclercq, B Cazenave, B Pilmis, B Henry, ... The Lancet Infectious Diseases 17 (5), 510-519, 2017 | 483 | 2017 |
| Autoantibodies neutralizing type I IFNs are present in~ 4% of uninfected individuals over 70 years old and account for~ 20% of COVID-19 deaths P Bastard, A Gervais, T Le Voyer, J Rosain, Q Philippot, J Manry, ... Science immunology 6 (62), eabl4340, 2021 | 435 | 2021 |
| Clinical recurrences of COVID-19 symptoms after recovery: Viral relapse, reinfection or inflammatory rebound? M Gousseff, P Penot, L Gallay, D Batisse, N Benech, K Bouiller, ... Journal of Infection 81 (5), 816-846, 2020 | 350 | 2020 |
| Sternal wound infection after cardiac surgery: incidence and risk factors according to clinical presentation A Lemaignen, G Birgand, W Ghodhbane, S Alkhoder, I Lolom, S Belorgey, ... Clinical Microbiology and Infection 21 (7), 674. e11-674. e18, 2015 | 205 | 2015 |
| The risk of COVID-19 death is much greater and age dependent with type I IFN autoantibodies J Manry, P Bastard, A Gervais, T Le Voyer, J Rosain, Q Philippot, ... Proceedings of the National Academy of Sciences 119 (21), 2022 | 128 | 2022 |
| COVID-19 symptoms at hospital admission vary with age and sex: results from the ISARIC prospective multinational observational study Infection 49 (5), 889-905, 2021 | 80 | 2021 |
| Dolutegravir monotherapy versus dolutegravir/abacavir/lamivudine for virologically suppressed people living with chronic human immunodeficiency virus infection: the randomized … L Hocqueloux, F Raffi, T Prazuck, L Bernard, S Sunder, JL Esnault, D Rey, ... Clinical Infectious Diseases 69 (9), 1498-1505, 2019 | 67 | 2019 |
| Characteristics of and risk factors for severe neurological deficit in patients with pyogenic vertebral osteomyelitis: A case–control study A Lemaignen, I Ghout, A Dinh, G Gras, B Fantin, V Zarrouk, R Carlier, ... Medicine 96 (21), e6387, 2017 | 62 | 2017 |
| Clinical and Biological Characteristics of 40 Patients With Neurosyphilis and Evaluation of Treponema pallidum Nested Polymerase Chain Reaction in … C Vanhaecke, P Grange, N Benhaddou, P Blanche, D Salmon, P Parize, ... Clinical Infectious Diseases 63 (9), 1180-1186, 2016 | 57 | 2016 |
| Incidence, characteristics, and mortality of infective endocarditis in France in 2011 S Sunder, L Grammatico-Guillon, A Lemaignen, M Lacasse, C Gaborit, ... PLoS One 14 (10), e0223857, 2019 | 52 | 2019 |
| Pyogenic vertebral osteomyelitis of the elderly: characteristics and outcomes J Courjon, A Lemaignen, I Ghout, A Therby, N Belmatoug, A Dinh, G Gras, ... PLoS One 12 (12), e0188470, 2017 | 50 | 2017 |
| Community-acquired bacterial meningitis in adults: in-hospital prognosis, long-term disability and determinants of outcome in a multicentre prospective cohort S Tubiana, E Varon, C Biron, MC Ploy, B Mourvillier, MK Taha, M Revest, ... Clinical Microbiology and Infection 26 (9), 1192-1200, 2020 | 46 | 2020 |
| Antibiotics and chronic kidney disease: Dose adjustment update for infectious disease clinical practice B Aloy, V Launay-Vacher, A Bleibtreu, P Bortolotti, E Faure, A Filali, ... Medecine et maladies infectieuses 50 (4), 323-331, 2020 | 34 | 2020 |
| Mpox in people with past infection or a complete vaccination course: a global case series A Hazra, J Zucker, E Bell, J Flores, L Gordon, O Mitjà, C Suñer, ... The Lancet Infectious Diseases 24 (1), 57-64, 2024 | 33 | 2024 |
| Impact on disease mortality of clinical, biological, and virological characteristics at hospital admission and overtime in COVID‐19 patients Y Yazdanpanah, French COVID Cohort Investigators and Study Group, ... Journal of Medical Virology 93 (4), 2149-2159, 2021 | 33 | 2021 |
| Four-days-a-week antiretroviral maintenance therapy in virologically controlled HIV-1-infected adults: the ANRS 162-4D trial P de Truchis, L Assoumou, R Landman, D Mathez, D Le Dû, J Bellet, ... Journal of Antimicrobial Chemotherapy 73 (3), 738-747, 2018 | 33 | 2018 |
| The value of open-source clinical science in pandemic response: lessons from ISARIC A Abbas, SA Abdukahil, NN Abdulkadir, R Abe, L Abel, L Absil, S Acharya, ... The Lancet infectious diseases 21 (12), 1623-1624, 2021 | 32 | 2021 |
| A new mechanism of resistance of human immunodeficiency virus type 2 to integrase inhibitors: a 5-amino-acid insertion in the integrase C-terminal domain Q Le Hingrat, G Collin, M Lê, G Peytavin, B Visseaux, M Bertine, ... Clinical Infectious Diseases 69 (4), 657-667, 2019 | 31 | 2019 |
| ISARIC-COVID-19 dataset: a prospective, standardized, global dataset of patients hospitalized with COVID-19 M Etienne, N Ettalhaoui, AG Everding, M Evers, I Fabre, M Fabre, ... Scientific data 9 (1), 454, 2022 | 26 | 2022 |
